Breast cancer gene test patent litigation: Special leave granted

The High Court has granted special leave to appeal in the matter of D’Arcy v Myriad Genetics Inc [2014] FCAFC 115.

The decision appealed from concerned a patent including claims for isolated nucleic acid and in particular whether claims to composition comprising isolated nucleic acid are for a manner of manufacture for purposes of s 18(1)(a) of Patents Act 1990 (Cth).

One Reply to “Breast cancer gene test patent litigation: Special leave granted”

Comments are closed.